The Ministry of Health wishes to thank the participants of the following working groups for the design, development and implementation of the Alzheimer’s Drug Therapy Initiative:
ADTI Education Working Group
Members
Dr. Martha Donnelly, Chair, UBC-Psychiatry and Family Practice
Dr. Kendall Ho, UBC-Continuing Professional Development & Knowledge Translation
Dr. Duncan Robertson, The Lodge at Broadmead
Dr. Kathryn Bell, Geriatrician, Vancouver Coastal Health
Dr. Doug Drummond, Prince George Regional Hospital
Dr. Rhonda Malyuk, Riverview Hospital
Elaine Unsworth, Clinical Nurse Specialist, Providence Health Care
Betty Sinclair, Director of Training and Education, Alzheimer Society of BC
Luke Ferdinands, UBC-Continuing Professional Development & Knowledge Translation
Paul Pallan, Vice-President, Hollander Analytical Services
Ron Mattson, Project Manager, Pharmaceutical Services Division, Ministry of Health
Terms of Reference:
provide advice and recommendations on physician education
provide advice and recommendation on types of training required
provide advice on training to inform content of future curricula
provide advice on whether training should be voluntary or mandatory
recommend agencies to provide and deliver training
estimate initial and ongoing resources required to provide training
provide advice to the ADTI Project Advisory Committee
ADTI Study Design Working Group
Members
Dr. Neena Chappell, Chair, UVic Professor of Sociology/Centre on Aging, Canada Research Chair in Social Gerontology
Dr. Howard Feldman, UBC Professor and Head of Neurology
Dr. Phillip Lee, Geriatric Medicine, St. Paul’s Hospital
Dr. Robert Hogg, Director, HIV/AIDS Treatment Program, BC Centre for Excellence in HIV/AIDS
Dr. Kiran Rabheru, Clinical Associate Professor and Geriatric Psychiatrist, VGH/UBC/Riverview
Dr. Malcolm Maclure, Adjunct Professor, School of Health Information Science, UVIC and Research Officer, Ministry of Health
Dr. Marcus Hollander, President, Hollander Analytical Services
Paul Pallan, Vice-President, Hollander Analytical Services
Ron Mattson, Project Manager and representative, Pharmaceutical Services Division, Ministry of Health
Terms of Reference
provide study design consistent with outcome of the July 2006 Alzheimer’s Forum
make recommendations on eligibility criteria for Alzheimer’s Drug Therapy Initiative
develop/identify measurement tools for determining outcome from Alzheimer’s studies
develop criteria for judging outcome of Alzheimer’s drug therapy
determine data and sources of data to be collected as part of the research studies
provide advice on possible external funding sources/implementation issues
establish subgroups to assist with details of studies/implementation
recommend starting date and length of study component
call upon individuals to assist with study
ADTI Project Advisory Committee
Members
Bob Nakagawa, PharmD, Chair, ADM Pharmaceutical Service Division, Ministry of Health
Rosemary Rawnsley, Executive Director, Alzheimer Society of B.C.
Dr. B. Lynn Beattie, Professor Emeritus, Geriatric Medicine, UBC
Dr. Chris Rauscher, Ministry of Health / Vancouver Coastal Health Authority
Eric Lun, PharmD., Executive Director, Drug Intelligence, Pharmaceutical Services Division, Ministry of Health
Dr. Elisabeth Drance, Geriatric Psychiatrist, Clinical Associate Professor, UBC
Paul Pallan, Vice-President, Hollander Analytical Services
Ron Mattson, Project Manager, Pharmaceutical Services Division, Ministry of Health
Terms of Reference
provide leadership for the Alzheimer’s Drug Therapy Initiative
provide advice and recommendation to Pharmaceutical Services Division and project management
provide guidance to Education Working Group and Study Design Working Group
monitor the work of the Education Working Group and the Study Design Working Group
acts as alink between the initiative and other provincial bodies (e.g, BCMA, other initiatives)
